Clinical Trial Update: The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and efficacy of an anti-EGFR humanized monoclonal antibody combined with chemotherapy in advanced solid tumors; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Anti-EGFR humanized monoclonal antibody (unspecified)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED